MedTrace Logo

Ayurveda as Prophylaxis for Suspected COVID-19 Patients

NCT04395976 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-03-02

No results posted yet for this study

Summary

Despite worldwide efforts to contain, manage and treat Covid-19, the pandemic is continuing to spread. This calls for an urgent clinically-proven prophylaxis and therapeutic strategy. Recent developments on the use of traditional medicines in Covid-19 management has drawn enough attention to start several research studies. Based on the Indian Traditional Medicine, Ayurveda's community initiatives, preliminary studies, and our experiential knowledge on Covid-19 settings, we propose present study to prevent the development of COVID-19 symptoms in people who live or have come contact with an individual diagnosed with COVID-19.

Conditions

Interventions

OTHER

Ayurveda

The Ayurveda intervention is multimodal and following the principles of Ayurveda as a whole medical system, each participants will be treated with individualised care. From the range of proven Ayurvedic Herbs, combination will be decided based on individual participants, his symptoms and his personality.

Sponsors & Collaborators

  • All Party Parliamentary Group - Indian Traditional Sciences

    collaborator UNKNOWN

  • University of Warwick

    collaborator OTHER

  • British Ayurvedic Medical Council

    lead OTHER

Principal Investigators

  • Vishwes Kulkarni · University of Warwick

  • Amarjeet S Bhamra · All Party Parliamentary Group - Indian Traditional Sciences

  • Neha Sharma · British Ayurvedic Medical Council

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-10
Primary Completion
2020-06-10
Completion
2020-09-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04395976 on ClinicalTrials.gov